Note: Ingredients listed on restricted chemical lists
EC/CAS
2451-62-9
Name of the chemical
1,3,5-Tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione (TGIC)
Concentration
2.5-10
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
0-1
General Information
Revision date
2014-04-17
Product name
JN182QF INTERPON 600 BLACK
1.2.1 Relevant identified uses
Electrostatic coating for use in industrial plants Akzo Nobel Coatings Inc 150 Columbia Street Reading, PA 19601 USA 1-610-372-3600
Emergency telephone
800-424-9300
Icons in SDS
Company Information
company name
Akzo Nobel Coatings Inc
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Emergency overview Physical state Solid. [Powder.] Odor : Odorless.
Signal word
WARNING!
Hazard statements
HARMFUL IF INHALED OR SWALLOWED. CAUSES EYE AND SKIN IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION. MAY CAUSE RESPIRATORY TRACT IRRITATION. CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA. POSSIBLE CANCER HAZARD - CONTAINS MATERIAL WHICH MAY CAUSE CANCER, BASED ON ANIMAL DATA.
Precautionary statements
Do not handle until all safety precautions have been read and understood. Obtain special instructions before use. Do not breathe dust. Do not ingest. Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Keep container tightly closed. Use personal protective equipment as required. Wash thoroughly after handling.
Potential Acute Health Effects
Inhalation Toxic by inhalation. Slightly irritating to the respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion Toxic if swallowed. Skin Irritating to skin. May cause sensitization by skin contact. Eyes Irritating to eyes.
Potential chronic health
effects : Contains material that may cause target organ damage, based on animal data. Repeated or prolonged inhalation of dust may lead to chronic respiratory irritation. Once sensitized, a severe allergic reaction may occur when subsequently exposed to very low levels. Carcinogenicity : Contains material which may cause cancer, based on animal data. Risk of cancer depends on duration and level of exposure. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Target organs : Contains material which may cause damage to the following organs: the reproductive system, upper respiratory tract, skin, eyes. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : No specific data. Skin : Adverse symptoms may include the following: irritation redness Eyes : Adverse symptoms may include the following: pain or irritation watering redness Medical conditions Pre-existing skin disorders and disorders involving any other target organs mentioned in aggravated by over- this MSDS as being at risk may be aggravated by over-exposure to this product. exposure See toxicological information (Section 11)